Fund Holdings — venBio Partners LLC

Total Portfolio Value:
$667.20M
Total Bought:
$48.99M
Total Sold:
$26.35M
Net Transaction:
+$22.64M
Notable People:
Venbio Partners, L.P.
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
RAYZEBIO INCCOM5,158,1625,158,1620$114.51M$320.68M48.06%+$206.17M
ALX Oncology Holdings Inc.COM(ALXO)9,699,9259,699,9250$46.56M$144.43M21.65%+$97.87M
PHARVARIS N VCOM
COM
4,264,6724,919,504+654,832$89.00M$137.99M20.68%+$48.99M
Harmony Biosciences Holdings, Inc.COM(HRMY)1,035,3961,035,3960$33.93M$33.44M5.01%-$486.6K
ACELYRIN INCCOM3,852,4703,852,4700$39.18M$28.74M4.31%-$10.44M
ELEVATION ONCOLOGY INCCOM2,914,2552,914,2550$1.93M$1.56M0.23%-$366.0K
IMPEL PHARMACEUTICALS INCCOM2,759,7912,759,7910$1.19M$340.8K0.05%-$845.9K
VENTYX BIOSCIENCES INCCOM758,8000-758,800$26.35M$0—-$26.35M
Page 1 of 1
venBio Partners LLC — 13F Holdings — Q4 2023 | TickerTrail